ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 230,928 shares, the number of shares held increased 2.14% compared to the previous period and now represents 5.05% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 173,285 shares, the number of shares held increased 1.41% compared to the previous period and now represents 6.17% of the total position.

ARKG Investment Tracker position change: Decreased position in Tempus AI by 13,320 shares, the number of shares held decreased 0.98% compared to the previous period and now represents 4.26% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 17,652 shares, the number of shares held increased 0.62% compared to the previous period and now represents 3.6% of the total position.

ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 2,102 shares, the number of shares held decreased 0.11% compared to the previous period and now represents 4.32% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 532 shares, the number of shares held increased 4.07% compared to the previous period and now represents 0.86% of the total position.

ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 261,340 shares, the number of shares held decreased 2.11% compared to the previous period and now represents 1.62% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 25,784 shares, the number of shares held increased 0.22% compared to the previous period and now represents 7.57% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.

ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 12,873 shares, the number of shares held decreased 0.66% compared to the previous period and now represents 4.26% of the total position.

ARKG Investment Tracker position change: Decreased position in Exact Sciences by 2,376 shares, the number of shares held decreased 0.98% compared to the previous period and now represents 1.25% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 244,867 shares, the number of shares held decreased 2.11% compared to the previous period and now represents 7.3% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 89,915 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 7.46% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 112,816 shares, the number of shares held increased 0.85% compared to the previous period and now represents 1.62% of the total position.

ARKG Investment Tracker position change: Decreased position in Veeva by 288 shares, the number of shares held decreased 0.72% compared to the previous period and now represents 1.04% of the total position.

ARKG Investment Tracker position change: Increased position in ATAI Life Sciences B.V.* by 387,756 shares, the number of shares held increased 25.63% compared to the previous period and now represents 0.84% of the total position.

ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 186 shares, the number of shares held decreased 0.74% compared to the previous period and now represents 0.93% of the total position.

ARKG Investment Tracker position change: Decreased position in Tempus AI by 10,854 shares, the number of shares held decreased 0.74% compared to the previous period and now represents 12.11% of the total position.

ARKG Investment Tracker position change: Decreased position in Natera by 2,028 shares, the number of shares held decreased 0.74% compared to the previous period and now represents 4.6% of the total position.

ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 1,326 shares, the number of shares held increased 2.11% compared to the previous period and now represents 0.74% of the total position.